TG; fatty liver; abnormal glycometabolism.
甘油三酯；脂肪肝；糖代谢异常。
Objective To observe the glycometabolism in hyperthyroid patients.
目的甲状腺功能亢进患者的糖代谢情况。
Hence it is hopeful to exploit new therapeutic drugs by pharmacological interference glycometabolism pathway.
因此，通过对各种糖代谢通路进行有针对性的干预，有望开发出新型治疗药物。
The longer course, larger dosage and longer treatment, the higher incidence of glycometabolism abnormality and diabetes.
患者病程越长、药物剂量越大、治疗时间越长，糖代谢异常及糖尿病发生率越高。
Objective: to analyze the relationship of hepatocirrhosis patients' glycometabolism disorder and syndrome differentiating of TCM.
目的：分析肝硬变患者糖代谢异常与中医辨证分型的关系。
Early effective protection liver function and reasonable nutrition support is the key to prevent the hepatogenic glycometabolism.
早期有效的保护肝功能和合理的营养支持治疗是预防肝源性糖代谢障碍的关键。
Diabetes is metabolic endocrine disease which accompany disorder of glycometabolism. It is a common and frequently encountered disease that harms human health.
糖尿病是以糖代谢紊乱为主要表现的内分泌代谢性疾病，是当前危害人类健康的常见病、多发病。
From 4 aspects as diabetes, ischemic heart and brain diseases, strokes and tumors, this paper reviews the research advances of drug development based on interference in glycometabolism.
本文从糖尿病、缺血性心脑损伤、中风、肿瘤等4个方面，综述了近年来以糖代谢干预为基础的新药研究进展。
From 4 aspects as diabetes, ischemic heart and brain diseases, strokes and tumors, this paper reviews the research advances of drug development based on interference in glycometabolism.
本文从糖尿病、缺血性心脑损伤、中风、肿瘤等4个方面，综述了近年来以糖代谢干预为基础的新药研究进展。
应用推荐